Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria
Open Access
- 1 June 2010
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 77 (11), 962-973
- https://doi.org/10.1038/ki.2010.40
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Wnt/β-Catenin Signaling Promotes Podocyte Dysfunction and AlbuminuriaJournal of the American Society of Nephrology, 2009
- Met and the epidermal growth factor receptor act cooperatively to regulate final nephron number and maintain collecting duct morphologyDevelopment, 2009
- Adriamycin Alters Glomerular Endothelium to Induce ProteinuriaJournal of the American Society of Nephrology, 2009
- Hepatocyte Growth Factor Exerts Its Anti-Inflammatory Action by Disrupting Nuclear Factor-κB SignalingThe American Journal of Pathology, 2008
- Epithelial-to-Mesenchymal Transition Is a Potential Pathway Leading to Podocyte Dysfunction and ProteinuriaThe American Journal of Pathology, 2008
- HGF as a renotrophic and anti-fibrotic regulator in chronic renal diseaseFrontiers in Bioscience-Landmark, 2008
- The podocyte's response to injury: Role in proteinuria and glomerulosclerosisKidney International, 2006
- Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of actionAmerican Journal of Physiology-Renal Physiology, 2004
- Suppressions of chronic glomerular injuries and TGF-β1production by HGF in attenuation of murine diabetic nephropathyAmerican Journal of Physiology-Renal Physiology, 2004
- Hepatocyte Growth Factor, but Not Insulin-Like Growth Factor I, Protects Podocytes against Cyclosporin A-Induced ApoptosisThe American Journal of Pathology, 2001